People who supplement rescue inhalers with a second asthma medication sometimes get little relief at first, but there’s good news: Those who keep trying different options often find a medication that works, according to Rutgers researchers. The researchers analyzed data from 2,025 patients who used any of six FDA-approved severe asthma treatments known as “biologics” because they contain monoclonal antibodies found in living organisms. “The practical takeaway here is pretty simple: Patients who aren’t getting good relief from a particular biologic should try others,” said lead author Reynold A. Panettieri Jr., vice chancellor for translational medicine and science director at the Rutgers Institute for Translational Medicine. To read the full story.